Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in ...

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes while highlighting drug-specific advantages and the need to manage ...

Depression is one of the most widespread mental health disorders worldwide, affecting approximately 4% of the global ...

Scientists think they may have developed a new weight loss drug that is more than twice as effective as Ozempic with fewer negative side effects. GLP-1 injectable medications, which include Ozempic, ...

A new study on a drug widely prescribed for asthma is binding itself to receptors in the brain and is linked to severe mental health issues and suicide, according to new research. The Food and Drug ...

Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments. However, about half of the patients who take these drugs stop within a year because of unwanted side effects. 1,2 For ...

A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including seizures and a loss of muscle control, according to a recent review by the ...

A new study on asthma medication Singulair has raised concerns about its potential mental health side effects, USA Today reported Nov. 24. The study, presented by the FDA at the American College of ...

A key achievement of the Biden Administration was the passage of the Inflation Reduction Act (IRA) of 2022, with sweeping provisions designed to lower drug prices and spending under Medicare.

If you or someone you know is struggling with suicidal thoughts, you can call the U.S. National Suicide Prevention Lifeline at 988 any time day or night, or chat online. A new study on a drug widely ...